English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas

Gomes, C., Almeida, A., Barreira, A., Calheiros, J., Pinto, F., Abrantes, R., et al. (2019). Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas. Theranostics, 9(24), 7431-7446. doi:10.7150/thno.33858.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0004-E671-9 Version Permalink: http://hdl.handle.net/21.11116/0000-0005-5F80-0
Genre: Journal Article

Files

show Files
hide Files
:
Article.pdf (Publisher version), 3MB
Name:
Article.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Gomes, Catarina, Author
Almeida, Andreia1, Author              
Barreira, Ana, Author
Calheiros, Juliana, Author
Pinto, Filipe, Author
Abrantes, Rafaela, Author
Costa, Ana, Author
Polonia, Antonio, Author
Campos, Diana, Author
Osorio, Hugo, Author
Sousa, Hugo, Author
Pinto-de-Sousa, Joao, Author
Kolarich, Daniel1, Author              
Reis, Celso A., Author
Affiliations:
1Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society, ou_1863301              

Content

show
hide
Free keywords: Gastric Cancer; Carcinoembryonic antigen; Glycosylation; ST3Gal IV; Sialyl-Lewis X
 Abstract: Malignant transformation of gastric cells is accompanied by the deregulated expression of glycosyltransferases leading to the biosynthesis of tumor-associated glycans such as the sialyl-Lewis X antigen (SLe(x)). SLe(x) presence on cell surface glycoconjugates increases the invasive capacity of gastric cancer cells and is associated with tumor metastasis. ST3Gal IV enzyme is involved in the synthesis of SLe(x) antigen and overexpressed in gastric carcinomas. Herein, we identified the glycoproteins carrying SLe(x) in gastric cancer cells overexpressing ST3Gal IV enzyme and evaluated their biomarker potential for gastric carcinoma. Methods: SLe(x) modified glycoproteins were identified applying western blot and mass spectrometry. Immunoprecipitation, proximity ligation assay (PLA), E-selectin binding assay and CRISPR/cas9 knockout experiments were performed to characterize the presence of SLe(x) on the identified glycoprotein. Protein N-glycans of the SLe(x) protein carrier were in deep analyzed by porous-graphitized-carbon liquid-chromatography and tandem mass spectrometry glycomics. In silico expression analysis of alpha 2-3 sialyltransferase ST3Gal IV and SLe(x) protein carrier was performed and the conjoint expression of the SLe(x) modified glycoproteins evaluated by immunohistochemistry and PLA in a series of gastric carcinomas. Results: Carcinoembryonic antigen (CEA; CEACAM5) was identified and validated by different methodologies as a major carrier of SLe(x). N-glycomics of CEA revealed that complex N-glycans are capped with alpha 2-3 linked sialic acid (Neu5Aca2-3Gal beta 1-4GlcNAc). Data set analysis of ST3Gal IV and CEA showed that ST3Gal IV expression was associated with patient's poor survival, whereas CEA did not show any prognostic value. The co-expression of both CEA and SLeX was observed in 86,3% of gastric carcinoma cases and 74,5% of the total cases displayed the conjoint CEA+SLeX in situ PLA expression. This expression was associated with clinicopathological features of the tumors, including infiltrative pattern of tumor growth, presence of venous invasion and patient's poor survival. CEA immunoprecipitation from gastric carcinoma tissues also confirmed the presence of SLex. Conclusion: CEA is the major glycoprotein carrying SLe(x) in gastric carcinoma and the conjoint detection of CEA-SLe(x) is associated with aggressive tumor features highlighting its PLA detection as a biomarker of gastric cancer patient prognosis for theranostic applications.

Details

show
hide
Language(s):
 Dates: 2019-10-112019
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: DOI: 10.7150/thno.33858
ISI: 000489762100004
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Theranostics
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Lake Haven, NSW 2263, Australia : Ivyspring int. publ.
Pages: - Volume / Issue: 9 (24) Sequence Number: - Start / End Page: 7431 - 7446 Identifier: ISSN: 1838-7640